LGC has launched stability testing services, adding to the long-established drug development services delivered from its Fordham, Cambridgeshire site. This new service enables continuous recording and ...

LGC today launched a Proficiency Testing (PT) service for the detection of SARS-CoV-2 (COVID 19) by nucleic acid amplification testing, one of the first global schemes for COVID-19. As increasing ...

LGC, a British chemical and biological analytical services company, has been acquired by the European private equity firm Bridgepoint in a transaction valued at more than $400 million. The seller is ...